HIV clinical trials in Tampa, FL
5 studies for HIV are looking for participants at sites in and around Tampa (within about 30 miles). Open a study to see who can join and how to contact the study team.
REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE
RecruitingPhase 4
- CAN Community Health, Tampa
- Midway Specialty Care Center, Temple Terrace · 7 mi away
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
Recruiting
- Moffitt Cancer Center, Tampa
Screen2Prevent (S2P)
RecruitingHealthy volunteers welcome
- University of South Florida, Tampa
Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
RecruitingPhase 3
- MOORE Clinical Research, Inc d/b/a TrueBlue Clinical Research, Tampa
Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
RecruitingPhase 1/2
- GSK Investigational Site, Tampa
About HIV
HIV (human immunodeficiency virus) attacks the body’s immune system. There is no cure but it can be treated with medicines. To know if you have HIV, get tested.
HIV trials in other cities
- Washington, DC22 studies
- New York City, NY18 studies
- Houston, TX17 studies
- Miami, FL17 studies
- Baltimore, MD16 studies
- San Francisco, CA15 studies
- Chicago, IL14 studies
- Atlanta, GA14 studies
- Philadelphia, PA11 studies
- Boston, MA11 studies
- San Diego, CA10 studies
- Los Angeles, CA9 studies
Other studies in Tampa
- Non-Small Cell Lung Cancer51 studies
- Breast Cancer43 studies
- Cancer (all types)39 studies
- Colorectal Cancer33 studies
- Lung Cancer29 studies
- Acute Myeloid Leukemia29 studies
- Metastatic Cancer29 studies
- Pancreatic Cancer27 studies
- Ovarian Cancer20 studies
- Melanoma19 studies
- Prostate Cancer19 studies
- Myelodysplastic Syndromes19 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.